Reactions

Reactions

Reactions

When science hits the headlines, we seek the views of expert sources who assess the news rigorously and quickly, according to the available evidence.

Reaction: expert group warns of cancer epidemic in Europe in the next decade if health and research do not improve

A panel of experts set up by the journal The Lancet Oncology analyses the impacts of the covid-19 pandemic on cancer treatment and research and makes recommendations to mitigate these problems. With an estimated one million cancer diagnoses lost across Europe in the past two years, the team warns that the continent is heading for a cancer epidemic in the next decade if health systems and cancer research are not urgently prioritised. 

0

Reactions: WHO recommends immediate skin-to-skin contact instead of incubator for premature and low birth weight infants

The World Health Organisation (WHO) has issued a statement recommending skin-to-skin contact immediately after birth to improve the survival of premature and low birth weight babies. Until now, in clinical practice it was common for the first phase after birth to take place in the incubator.

0

Reactions to the results of the Global Carbon Budget 2022 report

The Global Carbon Project (GCP) today releases its Global Carbon Budget 2022 report. The main conclusion is that there is no sign of a decrease in global CO2 emissions and, at current levels, there is a 50 % chance of exceeding 1.5°C warming in nine years. The results will be published in the journal Earth System Science Data.

0

Reaction to study concluding that global covid-19 incidence is higher than reported

An international team with WHO participation concludes that global covid-19 infection rates may be higher than reported. The research, published in the journal PLOS Medicine, is based on a systematic review and meta-analysis of seroprevalence studies published between 1 January 2020 and 20 May 2022.

0

Reactions to clinical trial using CRISPR to modify patient's own T lymphocytes for cancer treatment

A pioneering phase 1 clinical trial has tested a type of cancer immunotherapy. Researchers have modified patients' own T-lymphocyte receptors using the CRISPR tool to direct them against specific targets on their own tumours. The results are published in the journal Nature.

0

Reaction to the study finding prion forms in the brains of people with dementia and Down syndrome

People with Down syndrome are at high risk of developing dementia very similar to that caused by Alzheimer's disease. A study published in the journal PNAS has found that in these people, as had been observed in "classic" Alzheimer's, the characteristic proteins of the disease have prion-like features.

0